Neuronetics (STIM) EBITDA Margin (2017 - 2026)
Neuronetics (STIM) reported EBITDA Margin of 26.11% for Q1 2026, up 834.0% year-over-year from 2.8% in Q1 2025, and down 116.28% on a QoQ basis from 12.07% in Q4 2025.
Neuronetics (STIM) has 10 years of EBITDA Margin data on file, last reported at 26.11% in Q1 2026.
- Quarterly EBITDA Margin rose 834.0% year-over-year to 26.11% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 19.4% (up 2389.0% YoY) and the FY2025 annual result came in at 21.08%, up 2508.0% from the prior year.
- EBITDA Margin slipped to 26.11% in Q1 2026 per STIM's latest filing, from 12.07% in the prior quarter.
- Across five years, EBITDA Margin topped out at 12.07% in Q4 2025 and bottomed at 71.47% in Q1 2022.
- The 5-year median for EBITDA Margin is 41.73% (2023), against an average of 40.78%.
- The widest annual swing landed in 2024, when EBITDA Margin tumbled 2921 bps; it then jumped 3893 bps in 2025.
- Tracing STIM's EBITDA Margin over 5 years: stood at 42.46% in 2022, then surged by 49 bps to 21.79% in 2023, then slumped by 134 bps to 51.0% in 2024, then surged by 76 bps to 12.07% in 2025, then sank by 116 bps to 26.11% in 2026.
- Per Business Quant, the three latest STIM EBITDA Margin figures stand at 26.11% (Q1 2026), 12.07% (Q4 2025), and 19.63% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn | -26.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.11% |
| Dec 31, 2025 | -12.07% |
| Sep 30, 2025 | -19.63% |
| Jun 30, 2025 | -21.15% |
| Mar 31, 2025 | -34.45% |
| Dec 31, 2024 | -51.00% |
| Sep 30, 2024 | -41.71% |
| Jun 30, 2024 | -51.71% |
| Mar 31, 2024 | -39.38% |
| Dec 31, 2023 | -21.79% |
| Sep 30, 2023 | -49.60% |
| Jun 30, 2023 | -41.73% |
| Mar 31, 2023 | -63.75% |
| Dec 31, 2022 | -42.46% |
| Sep 30, 2022 | -45.18% |
| Jun 30, 2022 | -59.99% |
| Mar 31, 2022 | -71.47% |
| Dec 31, 2021 | -45.99% |
| Sep 30, 2021 | -52.05% |
| Jun 30, 2021 | -46.22% |
| Mar 31, 2021 | -56.23% |
| Dec 31, 2020 | -17.07% |
| Sep 30, 2020 | -19.47% |
| Jun 30, 2020 | -70.41% |
| Mar 31, 2020 | -90.33% |
| Dec 31, 2019 | -39.98% |
| Sep 30, 2019 | -39.55% |
| Jun 30, 2019 | -39.87% |
| Mar 31, 2019 | -55.44% |
| Dec 31, 2018 | -36.21% |
| Sep 30, 2018 | -31.54% |
| Jun 30, 2018 | -39.51% |
| Mar 31, 2018 | -45.36% |
| Dec 31, 2017 | -34.96% |
| Sep 30, 2017 | -26.78% |
| Jun 30, 2017 | -25.00% |
| Mar 31, 2017 | -52.99% |